METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus

• Published in: BMC medicine 2024-11, Vol.22 (1), p.511-20, Article 511
• Main Authors: Liu, Yu, Wang, Xiaohua, Huang, Mingcheng, Luo, Ailing, Liu, Shanshan, Cai, Mansi, Li, Weinian, Yuan, Shiwen, Zheng, Zhihua, Liu, Xiaoping, Tang, Chun
• Format: Article
• Language: English
• Subjects: Adenosine - analogs & derivatives; Adenosine - metabolism; Adult; Analysis; Animals; Autoantibodies; Autoimmune diseases; Autoimmunity; B cells; Biological response modifiers; Blood; Bone marrow; Care and treatment; Cells; Chronic conditions; Creatinine; Damage; Diagnosis; Disease; DNA methylation; Dosage and administration; Enzyme-linked immunosorbent assay; Epigenetics; Ethylenediaminetetraacetic acid; Female; Females; Flow cytometry; Gene expression; Gene sequencing; Genes; Humans; Immune response; Immune system; Immunofluorescence; Immunoglobulin G; Immunoprecipitation; Infiltration; Injuries; Interferon; Interferon regulatory factor; Interferon regulatory factor 4; Interferon Regulatory Factors - genetics; Interferon Regulatory Factors - metabolism; Kidney - metabolism; Kidney - pathology; Kidney injury; Kidneys; Laboratory animals; Lupus; Lupus Erythematosus, Systemic - genetics; Lupus Erythematosus, Systemic - pathology; Male; Methylation; Methyltransferases; Methyltransferases - genetics; Methyltransferases - metabolism; Mice; Mice, Inbred MRL lpr; Middle Aged; mRNA; N6-methyladenosine; Pathogenesis; Plasma; Plasma cell; Plasma cells; Ribonucleic acid; RNA; RNA modification; RNA sequencing; Signal transduction; Spleen; Systemic lupus erythematosus; Testing
• ISSN: 1741-7015; 1741-7015
• DOI: 10.1186/s12916-024-03735-y

Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause. N6-methyladenosine (m6A) is the most common mRNA modification and participates in various immune processes such as interferon production and immune cell regulation. However, the role of m6A in dysregulated immune response of SLE remains unknown. PBMCs from SLE patients were collected to compare the m6A modification profile by methylated RNA immunoprecipitation sequencing (MeRIP-seq). Interferon regulatory factor 4 (IRF4) was identified by combination with MeRIP-seq and RNA-Seq. IRF4 and methyltransferase 3 (METTL3) were detected using qRT-PCR and WB. Clinical significance of IRF4 in SLE patients was explored subsequently. IRF4 expression in B cell subsets of female MRL/lpr mice was detected by flow cytometry. Adeno-associated viruses (AAV) including AAV9-METTL3-OE and/or AAV9-IRF4-sh were treated with female MRL/lpr mice. Autoantibody levels and kidney injury were tested by ELISA, pathological staining, and immunofluorescence. m6A level of IRF4 was detected by MeRIP-qPCR. The downstream effectors of IRF4 contributing to renal pathology were explored by RNA-seq and verified by qRT-PCR. m6A methylation features were obviously aberrant in SLE patients, and IRF4 was the upregulated gene modified by m6A. METTL3 and IRF4 expressions were elevated in SLE patients and kidney of MRL/lpr mice. Clinical analysis indicated that SLE patients with high IRF4 level were more prone to kidney damage. IRF4 expression was especially increased in plasma cells of MRL/lpr mice. METTL3 induced renal IRF4 expression, plasma creatinine, ANA and urine ALB levels, IgG and C3 deposition, and renal damage and plasma cell infiltration were aggravated in MRL/lpr mice. However, IRF4 depletion could partially reduce METTL3-induced kidney damage. Meanwhile, m6A level of IRF4 elevated with METTL3 overexpression. Also, the expression of Cxcl1, Bcl3, and Fos mRNA were significantly reduced after knockdown of IRF4, which were mainly involved in TNF signaling pathway. Our study confirmed that upregulated METTL3 promoting IRF4 expression in an m6A-dependent manner, thus causing plasma cell infiltration-mediated kidney damage of SLE. This provides new evidence for the role of m6A in SLE kidney injury.